Staff in the Senate Health, Education, Labor, and Pensions (HELP) committee, which Sanders chairs, estimate that widespread ...
The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and ...
Weight loss drugs have the potential to bankrupt the U.S. healthcare system, according to a May 15 report from Sen. Bernie Sanders's office. Mr. Sanders chairs the Senate Committee on Health, ...
If Novo Nordisk dropped the price of Wegovy in the U.S down to the price in Denmark, the U.S. health care system could pay for new weight loss drugs for 100% of adults with obesity for less than the ...
A closer look at the numbers helps to explain the shift in political discourse from coverage to affordability. Also in the news: pressure to reduce drug prices, removing insurance perks for seniors, ...
Sanders said he admires Denmark's welfare system and is appealing to Danes’ ingrained sense of social justice to put pressure ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life.
B ernie Sanders has launched a probe into the “outrageously high prices” that drug giant Novo Nordisk charges for Ozempic and ...
Good evening and welcome to the weekend! The most severe solar storm to hit the United States since 2005 is underway and is ...
Overall, 47% of patients reported medical debt related to their cancer treatment, with half carrying debt that exceeded ...